Knowledge of RNA folding is critical to understand the function of various RNA species^[@R1]^. Chemical probes have played key roles in transcriptome-wide RNA secondary structure studies^[@R2]^. Increasing number of methods have been developed in recent years for high-throughput RNA structure mapping^[@R3]--[@R11]^. Two notable classes of chemical probes, DMS and SHAPE, enable transcriptome-wide *in vivo* RNA structurome mapping^[@R12]^. Both methods are effective, but with significant space for improvement. DMS is toxic at high concentration and mostly methylates the Hoogsteen face of bases; SHAPE molecules are hydrolytically unstable and label the 2'-OH of sugar instead of the bases^[@R13],[@R14]^. A more specific, non-toxic reagent that rapidly labels the Watson-Crick interface under mild conditions will offer additional advantage for *in vivo* RNA labeling and RNA secondary structure probing.

EDC (ethyl-3-(3-dimethylaminopropyl)carbodiimide), NAz (Nicotinoyl azide), glyoxal and its derivatives, were recently developed to expand the toolbox of probing RNA secondary structures in a low-throughput manner^[@R15]--[@R18]^. Kethoxal (1,1-dihydroxy-3-ethoxy-2-butanone) is known to react with guanines in single-stranded RNA (ssRNA) under mild conditions, which induces reverse transcription (RT) stop^[@R19]^. It could also react with inosine to form an unstable hemiacetal adduct^[@R20]^. However, lack of synthetic routes to modified kethoxal hampered its use for transcriptome-wide study. Here, with a new synthetic design ([Supplementary Note 1](#SD1){ref-type="supplementary-material"}), we report the preparation of azido-kethoxal (N~3~-kethoxal, 1) for the specific labeling of the N1 and N2 positions at the Watson-Crick interface of guanines in ssRNA ([Figure 1a](#F1){ref-type="fig"}). The azido group offers a bioorthogonal handle that can be modified with a biotin or dyes for enrichment or other applications^[@R10]^. In addition, the reversibility of the kethoxal-guanine reaction under alkaline or heating conditions^[@R19]^ provides an additional advantage in the RT-stop-based RNA structure mapping via producing read-through controls after removing the kethoxal labels.

N~3~-kethoxal only reacts with guanine in ssRNA and is inert with other nucleic bases ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}, [Figure 1b](#F1){ref-type="fig"}). Among chemically modified guanines, N~3~-kethoxal does not react with m^1^G and m^2^G but can label m^7^G, verifying that N~3~-kethoxal specifically modifies the N1 and N2 positions of guanine ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). In synthetic RNA oligos, all guanines in the guanine-containing oligos were labeled by N~3~-kethoxal, while the oligo without guanine showed no reaction ([Supplementary Figure 2](#SD1){ref-type="supplementary-material"}). N~3~-kethoxal exhibits higher RNA labeling activity compared with other reported RNA secondary structure probes, including DMS, NAI, glyoxal and EDC ([Supplementary Figure 3](#SD1){ref-type="supplementary-material"}). As shown by gel electrophoresis, dot blot, and mass spectrum analysis ([Figure 1c](#F1){ref-type="fig"}, [Supplementary Figure 4](#SD1){ref-type="supplementary-material"}), N~3~-kethoxal-modified RNAs can be successfully biotinylated, which can then be enriched by streptavidin-conjugated beads, in order to increase the signal-to-noise ratio in biological applications.

We evaluated cell-based labeling efficiency by adding N~3~-kethoxal into the culture medium of mouse embryonic stem cells (mESC) directly. Dot blotting of biotinylated RNA indicated that N~3~-kethoxal could permeate into living cells efficiently in one minute, with the signal saturated in five minutes, suggesting a quick cell penetration and high labeling efficiency of N~3~-kethoxal ([Figure 1d](#F1){ref-type="fig"}). The fast labeling is also confirmed by high-throughput sequencing results with G-stop ratio increased from 1 min and reached the maximum after 2.5 min ([Supplementary Figure 5](#SD1){ref-type="supplementary-material"}). The rapid labeling property enables N~3~-kethoxal to be used in transient events such as stress response, signaling, etc.

The kethoxal-guanine adduct is unstable under alkaline conditions^[@R19]^. By adding excessive guanine monomers to trap dissociated N~3~-kethoxal, the labeling can be removed to yield unmodified RNAs in a neutral buffer within a shorter period of time ([Supplementary Figure 6a](#SD1){ref-type="supplementary-material"}). The excessive GTP almost completely remove the N~3~-kethoxal modification on the labeled RNA within 8 hours at 37 °C ([Supplementary Figure 6b](#SD1){ref-type="supplementary-material"}) or within 10 min at 95 °C ([Figure 1e](#F1){ref-type="fig"}, [Supplementary Figure 6c](#SD1){ref-type="supplementary-material"}). The labeling adduct of kethoxal-guanine could be stabilized in borate buffer as previously reported^[@R19]^, providing flexibility to manipulate the N~3~-kethoxal adduct on RNA.

We next combined N~3~-kethoxal probing with deep sequencing (Keth-seq) to probe RNA secondary structures in mESC. In each experiment, we constructed three different RNA libraries, including an N~3~-kethoxal-modified RNA, a no-treatment control sample, and an N~3~-kethoxal-removal sample made by erasing the N~3~-kethoxal labeling before the reverse transcription ([Supplementary Figure 7](#SD1){ref-type="supplementary-material"}). We observed a high correlation at both RPKM ([Supplementary Figure 8a](#SD1){ref-type="supplementary-material"}) and RT-stop level between Keth-seq replicates ([Figure 2a](#F2){ref-type="fig"}), indicating that Keth-seq is highly reproducible. Additionally, in the N~3~-kethoxal sample, guanine (\>80%) dominates the RT-stopped sites among all reads, with no RT stop bias across all four bases in the no-treatment control sample ([Supplementary Figure 8b](#SD1){ref-type="supplementary-material"}), confirming that N~3~-kethoxal is highly selective to guanine. RT-stopping sites in N~3~-kethoxal-removal samples decreased dramatically to a similar level to the no-treatment control, indicating that N~3~-kethoxal modification was almost completely removed during the reversal process ([Supplementary Figure 8b](#SD1){ref-type="supplementary-material"}). In mRNA mt-Atp8, for instance, we observed more full-length RNA fragments in the N~3~-kethoxal-removal sample than that in the no-treatment control sample, suggesting that the RT stopped sites could be more confidently identified using the N~3~-kethoxal-removal sample as the 'background' ([Supplementary Figure 9](#SD1){ref-type="supplementary-material"}).

To validate Keth-seq, we analyzed guanine signals from Keth-seq and compared with icSHAPE both globally and at the transcript level^[@R10]^. For every common transcript (n = 455), we calculated a correlation coefficient between Keth-seq and icSHAPE by using their reactivity profile on all guanines, and plotted the whole distribution as an accumulative curve ([Figure 2b](#F2){ref-type="fig"}). About 80% of the transcripts show a positive correlation (Pearson correlation coefficient \>= 0.4, [Figure 2b](#F2){ref-type="fig"}), indicating that Keth-seq agrees well with the established icSHAPE technology. To directly evaluate the accuracy of Keth-seq in determining RNA secondary structure, we compared the reactivity profile of Keth-seq with icSHAPE on all guanines in the mouse 18S ribosomal RNA with the known structure model from the RNA STRAND database (id: CRW_00356)^[@R21]^. Keth-seq reactivity profile achieves a higher AUC than icSHAPE in fitting the 18S ribosomal RNA model (Keth-seq = 0.81, icSHAPE = 0.71) ([Figure 2c](#F2){ref-type="fig"}). More specifically, Keth-seq shows a higher reactivity score than icSHAPE for single-stranded G nucleotides and thus more accurately revealing unpaired Gs ([Supplementary Figure 10a](#SD1){ref-type="supplementary-material"}), though both methods similarly agree well with the 18S model on its double-stranded areas ([Figure 2c](#F2){ref-type="fig"}).

We then extended the comparison by using all available mouse RNA secondary structure models from Rfam database, and found Keth-seq achieves a higher AUC than icSHAPE for most of these RNAs ([Figure 2c](#F2){ref-type="fig"}). In addition, we compared Keth-seq and DMS-seq^[@R6]^ by evaluating their performance on human 18S RNA (id: CRW_00347) and showed that Keth-seq achieve a comparable accuracy as DMS-seq with similar AUCs obtained ([Supplementary Figure 10b](#SD1){ref-type="supplementary-material"}). Furthermore, we applied Keth-seq to probe RNA structure both *in vivo* and *in vitro* for mESCs and used Gini index to measure the structural evenness of RNAs^[@R6]^. Consistent with previous findings, we observed that RNAs *in vitro* showed higher Gini index than that *in vivo* ([Supplementary Figure 10c](#SD1){ref-type="supplementary-material"}--[d](#SD1){ref-type="supplementary-material"}), validating the folding complexity of cellular RNAs and the feasibility of Keth-seq for *in vivo* detection.

Formation of RNA G-quadruplexes (rG4) from isolated RNAs has been shown in different studies. However, the *in vivo* detection of rG4 remains challenging^[@R22],[@R23]^. As N~3~-kethoxal is highly specific towards labeling N1 and N2 positions of guanine and can be enriched, Keth-seq can be sensitive on probing the potential presence of the rG4 structure in live cells. After demonstrating that N~3~-kethoxal can detect rG4 *in vitro* ([Supplementary Figure 11a](#SD1){ref-type="supplementary-material"}--[c](#SD1){ref-type="supplementary-material"}), we conducted Keth-seq using isolated HeLa RNA or in live HeLa cell in the presence or absence of PDS, which has been shown to induce rG4 formation inside cells^[@R24]^. We first explored the structure landscape of previously identified rG4 regions by rG4-seq under PDS treatment *in vitro*^[@R22]^, and detected 95 regions with structure information detected by Keth-seq under both native and PDS treatment conditions ([Supplementary Figure 12a](#SD1){ref-type="supplementary-material"}). In the PDS treated samples, these regions show a higher Gini index than the control sample, suggesting the formation of rG4 under PDS treatment ([Figure 2d](#F2){ref-type="fig"}). Consistent with previous observations^[@R22]^, these rG4 regions preferentially occur at UTR regions ([Supplementary Figure 12b](#SD1){ref-type="supplementary-material"}) and are associated with biological pathways ([Supplementary Figure 12c](#SD1){ref-type="supplementary-material"}) including translation, transcription and metabolism, suggesting potential regulatory roles of rG4s.

To further explore whether rG4 can fold in live cells, we performed similar analysis using *in vivo* Keth-seq data and detected 105 previously identified rG4 regions under both native and PDS treatment conditions ([Supplementary Figure 12d](#SD1){ref-type="supplementary-material"}). 69 of these 105 regions showed higher Gini index under PDS treatment compared with the control, indicating that rG4 structure could potentially form at these regions in live cells. The genomic context distribution and top enriched biological pathways of these regions are both similar to that *in vitro* ([Supplementary Figure 12e](#SD1){ref-type="supplementary-material"}--[f](#SD1){ref-type="supplementary-material"}). We included examples where the signal in the defined rG4 regions in the PDS sample is lower than that in the control sample ([Figure 2e](#F2){ref-type="fig"}, [Supplementary Figure 13](#SD1){ref-type="supplementary-material"}), indicating that PDS treatment induces rG4 formation both *in vitro* and in live cells.

We noted that only a small subset of rG4s possibilities from the rG4 dataset^[@R22]^ are detected by Keth-seq. It could be due to insufficient sequencing depth or possible that chemical labeling only detects kinetically stable structures and may miss highly dynamic rG4s^[@R25]^. Though rG4s detected *in vitro* may not fold *in vivo*^[@R23]^, our study does suggest that a portion of rG4s could exist *in situ*.

In summary, we showed that N~3~-kethoxal readily labels RNA and established Keth-seq as an effective method for transcriptome-wide RNA secondary structure mapping in live cells. Because of the high selectivity and reactivity of N~3~-kethoxal labeling of guanines in single-stranded RNA, Keth-seq is able to map secondary structures such as rG4 under mild conditions. The efficient live cell RNA labeling by N~3~-kethoxal provides an approach that could be expanded for RNA enrichment, RNA targeting and RNA proximity studies in the future.

ONLINE METHODS {#S1}
==============

Synthesis of N~3~-kethoxal. {#S2}
---------------------------

The synthesis of N~3~-kethoxal and the characterization of compounds (^1^H NMR, ^13^C NMR and HRMS) are included in [Supplementary Note 1](#SD1){ref-type="supplementary-material"}.

General chemical and biological materials. {#S3}
------------------------------------------

All chemical reagents for N~3~-kethoxal synthesis were purchased from commercial sources. RNA oligos were purchased from Integrated DNA Technologies, Inc. (IDT) and Takara Biomedical Technology Co., Ltd. Buffer salts and chemical reagents for N~3~-kethoxal synthesis were purchased from commercial sources. Superscript III, Dynabeads® MyOne™ Streptavidin C1 was purchased from Life technologies. T4 PNK, T4 RNL2tr K227Q, 5'-Deadenylase, RecJ~f~ were purchased from New England Biolabs. CircLigaseII was purchase from Epicentre® (an Illumina company). DBCO-Biotin was purchase from Click Chemistry Tools LLC (A116--10). All RNase-free solutions were prepared from DEPC-treated MilliQ-water.

The reaction of N~3~-kethoxal and RNA oligo. {#S4}
--------------------------------------------

The reaction was generally performed with following protocol: 100 pmol RNA oligo and 1 μmol N~3~-kethoxal was incubated in total 10 μL solution in kethoxal reaction buffer (0.1 M sodium cacodylate, 10 mM MgCl~2~, pH 7.0) at 37 °C for 10 min. To induce rG4 folding *in vitro*, RNA were denatured at 95 °C for 5 min then cooled to 4 °C for 5 min, before 1 M KCl (2 μL), 0.1 M sodium cacodylate buffer (pH 7.0) and PDS (final concentration of 5 μM) were added. The mixture was incubated at 37 °C for 10 min to achieve equilibration. N~3~-kethoxal was then added to the reaction mixture to react with folded RNA. The final reaction volume was 10 μL. The modified RNA was purified by Micro Bio-Spin™ P-6 Gel Columns (Biorad, 7326222). The purified labeled RNA can be used for further used for mass spectrometry, gel electrophoresis, primer extension assay and copper-free click reaction with biotin-DBCO.

Remove N~3~-kethoxal modification from N~3~-kethoxal labelled RNA. {#S5}
------------------------------------------------------------------

The detailed protocol of N~3~-kethoxal modification erasing was listed in the step 5 "N~3~-kethoxal-remove sample preparation" of Keth-seq protocol in supporting information. Generally, the purified N~3~-kethoxal modified RNA was incubated with high concentration of GTP (1/2 volume of the reaction solution, final concentration is 50 mM) at 37 °C for 6 hours or at 95 °C for 10 min. Higher temperature is benefit to remove the N~3~-kethoxal modification.

Fixation of N~3~-kethoxal modification in RNA. {#S6}
----------------------------------------------

The N~3~-kethoxal modification in RNA can be fixed in the presence of borate buffer. The solution of N~3~-kethoxal labelled RNA was mixed with 1/10 volume of stock borate buffer (final concentration: 50 mM; stock borate buffer: 500 mM potassium borate, pH 7.0, pH was monitored while adding potassium hydroxide pellets to 500 mM boric acid). The borate buffer fixation was used in step 2, 4, 6 of Keth-seq protocol in supporting information.

MALDI-TOF-MS analysis of N~3~-kethoxal labelled RNA oligo. {#S7}
----------------------------------------------------------

The N~3~-kethoxal labelled RNA was purified by Micro Bio-Spin™ P-6 Gel Columns. Meanwhile the buffer exchange was occurred from kethoxal reaction buffer to Tris buffer that can be directly used in MALDI-TOF-MS experiment without extra desalt step. One microliter of product solution was mixed with one microliter matrix which include 8:1 volume ratio of 2'4'6'-trihydroxyacetophenone (THAP, 10 mg/mL in 50% CH~3~CN/H~2~O) : ammonium citrate (50 mg/mL in H~2~O). Then the mixture was spotted on the MALDI sample plate, dried and analyzed by Bruker Ultraflextreme MALDI-TOF-TOF Mass Spectrometers.

The selectivity of N~3~-kethoxal to ssRNA by gel electrophoresis. {#S8}
-----------------------------------------------------------------

The complementary RNA oligos FS1 (Fluorescent RNA oligo) and S2 were hybridized to double-strand RNA (dsRNA) with the ratio of FS1 : S2 = 1.2 : 1 to ensure all FS1 was involved in the formation of dsRNA. After the reaction with N~3~-kethoxal, the purified product by Micro Bio-Spin™ P-6 Gel Columns was analyzed by denaturing gel electrophoresis (Novex™ TBE-Urea Gels, 15%, Invitrogen, EC6885BOX). Gel Imaging was collected in Pharos FX Molecular imager (Bio-Rad, USA).

RNA sequence:

FS1: 5'-FAM-GAGCAGCUUUAGUUUAGAUCGAGUGUA,

S2: UACACUCGAUCUAAACUAAAGCUGCUC

HPLC condition. {#S9}
---------------

The product of N~3~-kethoxal with for RNA nucleic bases was analyzed using LC-6AD (Shimadzu, Japan) HPLC instrument, which equipped with an Inertsil ODS-SP column (5 μm, 250×4.6 mm) (GL Science lnc. Japan). The phase A (100 mM TEAA buffer, pH = 7.0) and phase B (CH~3~CN) were used as eluents with a flow rate of 1 mL/min at 35 °C (B conc.: 5-5-30% / 0-5-30 min).

The biotinylation of N~3~-kethoxal labelled RNA and dot blot assay. {#S10}
-------------------------------------------------------------------

*In vitro* study: The purified N~3~-kethoxal RNA was incubated with DBCO-Biotin at 37 °C for 2 hours in present of RNase inhibitor, borate buffer (step 2 biotinylation of Keth-seq protocol in supporting information). For RNA oligo analysis, the biotinylated product was purified by Micro Bio-Spin™ P-6 Gel Columns and subject to dot blot assay and MALDI-TOF-MS detection; for total RNA or mRNA, the product was purified by RNA clean & concentrator 5 (zymo research, R1015) and subject to further experiments.

*In vivo* study: 10 μL N~3~-kethoxal was added into the cell culture medium in 100 mm cell culture dish with nearly 80 % confluent mES cells. After incubation at 37 °C in CO~2~ incubator for a specific time, the medium was aspirated and the cells were washed three times by PBS. The total RNA was isolated by Trizol™ reagent (Invitrogen, 15596026) or Qiagen RNeasy plus mini kit (Qiagen, 74134). mRNA was isolated by Dynabeads™ mRNA DIRECT™ Purification Kit (Invitrogen, 61011). The biotinylation step was same as *in vitro* study. The biotinylated RNA was purified by RNA clean & concentrator 5.

Dot blot assay: one microliter RNA (100 ng/μL) sample was spotted onto the Amersham Hybond-N+ membrane (RPN119B, GE Healthcare) and UV crosslinked to the membrane by UVP HL-2000 hybriLinker. The membrane was washed using 1 × PBST (0.1% tween-20) and blocked with 5% nonfat dry milk in 1 × PBST overnight at 4 °C. After four times wash using 1 × PBST with ten-minute interval, the streptavidin-horseradish peroxidase (1:15000 dilutions, streptavidin-HRP, Life Technologies, S-911) in 1 × PBST with 3% BSA was added and incubated at room temperature for 40 min. Then then membrane was washed using 1 × PBST with ten-minute interval again and developed by SuperSignal™ West Pico PLUS Chemiluminescent Substrate (Thermo Scientific, 34577). The membrane was washed by 1 × PBST again and stained by methylene blue solution (0.02% methylene blue in 0.3M sodium Acetate pH 5.2).

Primer extension assay. {#S11}
-----------------------

RNA templates (N~3~-kethoxal treated or not) were dissolved in 13.5 μL nuclease-free water. 1 μL of 10 μM FAM-labeled DNA primer, 2 μL reverse transcription buffer, 1 μL 0.1 M DTT, 1 μL 5 mM dNTPs and 1.5 μL RevertAid Reverse Transcriptase (200U/μL) were then added (total volume 20 μL). The G ladder was made by dideoxy sequencing method, with 2 μL of 10 mM corresponding ddNTP added to replace 2 μL of nuclease-free water. The reverse transcription was performed at 37 °C for 30 min, and then 20 μL of deionized formamide was added. The reaction mixture was immediately heated up to 95 °C for 10 min, then cooled down to 4 °C. The cDNAs were size fractionated by 20% denaturing polyacrylamide gel containing 8 M urea. The gel was scanned with Pharos FX Molecular imager (BioRad) operated in the fluorescence mode (λ~ex~ = 488 nm).

Keth-seq library preparation. {#S12}
-----------------------------

The library was prepared following a previously reported procedure with slight changes^[@R10]^. The detailed protocol was included in [Supplementary Note 2](#SD1){ref-type="supplementary-material"}. For *in vitro* library preparation, RNA was isolated and refolded in RNA folding mix buffer (100 mM HEPES, pH 8.0, 100 mM NaCl, 10 mM MgCl~2~). The refolded RNA was treated with N~3~-kethoxal and then used for library construction. For *in vivo* study, N~3~-kethoxal was added into the culture medium of mES cell or HeLa cell and the RNA was isolated to be used for library construction.

Isolated N~3~-kethoxal labeled RNA was biotinylated with water-soluble DBCO-biotin (Click Chemistry tool, A116) by copper-free click reaction, then fragmented by sonication. The RNA Fragmentation Reagent is not suitable for the fragmentation step of Keth-seq because high temperature will affect N~3~-kethoxal labeling in RNA. In addition, the borate buffer is also necessary in each step before cDNA production except the kethoxal-remove experiment. Fragmented RNA was subjected to end repair by T4 PNK, 3'-adaptor ligation (3'-adaptor: /5rApp/TGGAATTCTCGGGTGCCAAGG/3ddC/) followed by 3'-adaptor removing by 5'-Deadenylase and RecJf digestion. The ligation products were separated to two fractions, with 90% used to produce the N~3~-kethoxal library and the rest 10% used for N~3~-kethoxal-remove sample library.

For the N~3~-kethoxal sample, RT primer, dNTPs, SuperScript III, borate solution, and RNase inhibitor were mixed with RNA to perform reverse transcription (RT primer: /5Phos/DDDNNAACCNNNNGATCGTCGGACTGTAGAACTCTGAACAT/iSp18/GGATCC/iSp18/TACCTTGGCACCC). After cDNA synthesis, the cDNA-RNA was kept cool to avoid denature and was immediately subjected to immunoprecipitation by Dynabeads® MyOne™ Streptavidin C1. Beads were washed and the truncated cDNA was eluted by RNase A/T1 and RNase H digestion. For the N~3~-kethoxal-remove sample, RNA was incubated with GTP in nuclease-free water at 95 °C for 10 min to remove N~3~-kethoxal modification. The RNA was then purified and reverse transcription was performed similarly as the N~3~-kethoxal sample.

cDNA from N~3~-kethoxal sample and N~3~-kethoxal-remove sample were subjected to size selection by gel electrophoresis separation, which can remove the excess RT primers and the self-ligation product of primers. The purified cDNA was used for cDNA cyclization by CircLigaseII to obtain the circDNA. The circDNA were then amplified by PCR with short primers (F: 5'-TGGCACCCGAGAATTCCA; R: 5'-TTCAGAGTTCTACAGTCCGA). In this step, qPCR was performed to evaluate the cycle numbers of each samples to avoid over-amplification. After purification and size selection, a final library PCR amplification is performed using the full sequencing primers from TruSeq® Small RNA Sample Prep Kits of (Illumina). The products were purified by low melting point agarose gel and used for deep sequencing.

For the no-treatment control sample, RNA was isolated from cells without any N~3~-kethoxal treatment, followed by fragmentation, adaptor ligation, reverse transcription, cDNA cyclization and PCR amplification as described above to construct the library for deep sequencing.

Sequencing data processing. {#S13}
---------------------------

As the library structure is similar to that of icSHAPE, we used the same strategy to process the sequencing reads by using the icSHAPE scripts at ([https://github.com/qczhang/icSHAPE)^[@R10]^](https://github.com/qczhang/icSHAPE)10). Firstly, readCollapse.pl was used to collapse the reads with default parameter. Note that we include a barcode of random hexamer (NNNNNN) ligated to the fragments during library construction ([Supplementary Figure 14](#SD1){ref-type="supplementary-material"}). These random barcodes serve to identify PCR duplicates from real different fragments with the identical sequences. Reads with fully identical sequence (including the barcode and the insert fragment) were marked as PCR duplicates and filtered before subsequent analysis. But reads with different barcodes were retained, even they contain the identical insert fragments and subsequently mapped to the same start and end positions, as they actually represent different fragments in the library.

Then we used trimming.pl to cut potential adapter sequences (-l 13 -t 0 -c phred33 -a adapter.fa -m 0, adapter sequence: ATGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTGAAAAAAAAAA). Next, we mapped the clean reads to ribosomal RNAs, and the unmapped reads were mapped to the transcriptome (Gencode, mm10 for mouse and hg38 for human) using Bowtie with default parameters. We calculated reverse transcription (RT) stop signals using the script calcRT.pl. After evaluating correlation between different replicates (correlationRT.pl), we combined RT signals of replicates (combineRTreplicates.pl) for subsequent analysis, and then normalized them for both the kethoxal and the control samples respectively (normalizeRTfile.pl -m mean:vigintile2 -d 32 -l 32). A structure reactivity score for each nucleotide in each transcript was calculated by comparing the kethoxal sample (foreground) versus the control sample (background) using the script calcEnrich.pl (-w factor5:scaling1 -x 0.25). The calculation is based on following formula: A\*(RT\[kethoxal\] -- B\*RT\[control\])/BD\[control\], where RT means the RT stop count of the nucleotide in the sample, BD means the base density of the nucleotide, A and B are scaling factors to control the effects of subtraction. Our previous work on icSHAPE technology development trained the two scaling factors on mouse 5S ribosomal RNA, the structure of which has been determined by both high-throughput sequencing and low-throughput RT-stop gel analysis^[@R10],[@R26]^, by maximizing the correlation between calculated reactivity scores and gel-based results. We found that although the scaling factors performs the best around A = 10 and B = 0.25, they are relatively insensitive. We thus used the same parameters in Keth-Seq and we did observe high accuracy on known structures. Finally, to obtain high-quality scores, we only kept nucleotides with adequate sequencing coverage: filterEnrich.pl -T 2 -t 200 -s 5 -e 30. Here "-T 2" requires the minimal average number of RT stops over the whole transcript to be no less than 2; "-t 200" requires the base density of a nucleotide with reactivity to be no less than 200; and "-s 5 -e 30" is to trim away the first 5 and the last 30 nucleotides as they tend to have low sequencing quality scores.

For rG4 probing, we first converted the genomic coordinated of previously reported rG4 regions in HeLa cells^[@R22]^ to transcriptome coordinates^[@R27]^. The converted regions with \>=60% NULL value of structure scores from our Keth-seq experiments were filtered from subsequent analysis. The retained regions were used for comparison between +PDS and -PDS Keth-seq samples.

Comparison between Keth-seq and icSHAPE/DMS-seq. {#S14}
------------------------------------------------

To compare the performance of Keth-seq and icSHAPE, we collected known RNA secondary structure models from different sources, including the mouse 18S ribosomal RNA structure from the RNA STRAND database^[@R21]^ (CRW_00356) and the other 614 RNA structure models from the Rfam database^[@R28]^. Both Keth-seq and icSHAPE^[@R10]^ sequencing reads were remapped to these specific RNAs and the reactivity score profiles were calculated (18S rRNA and 31 other RNAs with structure information are common in the two experiments and retained). We calculated receiver operator characteristic (ROC) curves to measure to what degree the structural probing reactivity scores fits the reference structure model. Using different reactivity score cutoffs, each nucleotide can be predicted (classified) as single-stranded or double-stranded. A true positive is defined as a single-stranded base with a reactivity score higher than the cutoff. A true negative is defined as a paired base with a reactivity score lower than the cutoff. AUC is calculated using the signals of guanine nucleotides for Keth-seq while considering the signals of all four bases for icSHAPE. To compare Keth-seq with DMS-seq, we collected DMS-seq data^[@R6]^ for Fibroblast and K562 sample and evaluate the performance on human 18S ribosomal RNA (RNA STRAND id: CRW_00347). AUC is calculated using the signals of the adenine and cytosine nucleotides for DMS-seq. For 18S rRNA, we firstly parse the known 3D ribosome structure (PDB ID: 4V6X) and derive an accessibility score for each nucleotide. Only nucleotides with accessibility score great than 3 are retained for evaluation.

Calculating Gini index for regions. {#S15}
-----------------------------------

We followed a previously reported method to calculate the Gini index to measure the level of RNA structure formation^[@R6]^. In principle, a Gini index represents data evenness and a completely unfolded and a completely base-paired RNA would both have a low Gini index. However, in reality, a RNA usually has a comparable number of single-stranded and double-stranded nucleotides, and within a normal range, the Gini index of a RNA well correlates with its structure formation. To explore the correlation between RNA structureness and Gini index, we collected all mouse RNAs from the Rfam database (n = 614), the secondary structures of which have been determined. We performed a simulation analysis, where a random reactivity score is assigned to each nucleotide in the RNA, with a score in 0.5--1.0 for single stranded nucleotide, and a score in 0.0--0.5 for double-stranded nucleotide. Then a Gini index is calculated from the simulated reactivity profile. The random simulation was repeated 100 times. Clearly, we observed that, the higher the Gini index the more structured (higher double stranded nucleotides ratio) the RNA is ([Supplementary Figure 8c](#SD1){ref-type="supplementary-material"}). Also note that another measurement of RNA structure level is the average of reactivity scores, and we have repeated and confirmed all conclusions in the main text concerning Gini index with reactivity score average.

Assume the reactivity profile of a region is: $\left( {x_{1},x_{2},x_{3},\ldots,x_{n}} \right)$, where *x*~*n*~ is the reactivity score for base *n*. We calculate a Gini index value as follows: 1) Sort the reactivity value of the region in ascending order and take the summation $\left( {\textit{Sum} = {\sum_{j = 1}^{n}x_{j}}} \right)$ and accumulation $\left( {Acc_{j} = {\sum_{i = 1}^{j}x_{i}}} \right)$ 2) Calculate the accumulating area $\left( {\textit{Cumulating}_{\textit{area}} = {\sum_{j = 1}^{n}\left( {Acc_{j} - \frac{x_{j}}{2}} \right)}} \right)$ and fair area $\left( {\textit{Fair}_{\textit{area}} = \frac{\textit{Sum}^{*}\textit{n}}{2}} \right)$; 3) Calculate the Gini index value $\left( {\textit{Gini} = \frac{\textit{Fair}_{\textit{area}} - \textit{Cumulating}_{\textit{area}}}{\textit{Fair}_{\textit{area}}}} \right)$.
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![N~3~-kethoxal and experimental evaluation of its selectivity, cell permeability and reversibility.\
(**a**) The structure of N~3~-kethoxal and the reaction with guanine. (**b**) Denaturing gel electrophoresis demonstrating N~3~-kethoxal only react with single-strand RNA (ssRNA). (**c**) Upper: Denaturing gel electrophoresis analysis of the labelling reaction of kethoxal and N~3~-kethoxal with FAM-RNA oligo (5'-FAM-GAGCAGCUUUAGUUUAGAUCGAGUGUA, lane 1--3) and biotinylation with biotin-DBCO (lane 5, 6). Only N~3~-kethoxal labelled RNA can be biotinylated (lane 6). Bottom: Dot blot of RNA after labelling and Biotinylation reactions. Methylene blue dot results are listed as control. (**d**) Dot blot of isolated total RNA from mES cells which were treated by N~3~-kethoxal with different periods, 1, 5, 10, 15, 20 min. (**e**) Dot blot analysis of reversibility of N~3~-kethoxal labelled mRNA in present of 50 mM GTP at 95 °C. The N~3~-kethoxal modification in mRNA was removed thoroughly after 10 min incubation. Experiments were independently repeated twice with similar results obtained. Uncropped scans for b, c, d, and e are provided in [Supplementary Figure 15](#SD1){ref-type="supplementary-material"}.](nihms-1547030-f0001){#F1}

![Keth-seq method and the profile around rG4 regions.\
(**a**) Scatter plot of reverse transcription (RT) stop reads distribution between replicates for N~3~-kethoxal sample. The inset pie plots show RT stopped base distribution for replicate 2 (upper left, A: 604,222; T: 497,602; C: 481,596; G: 7,204,998) and replicate 1 (bottom right, A: 703,486; T: 586,297; C: 551,962; G: 8,683,824). (**b**) Accumulation plot of correlation coefficient between Keth-seq and icSHAPE for all transcript. For each common transcript, we calculate the Pearson correlation coefficient for structural signal of guanine bases. The inset plot shows all guanine reactivity between Keth-seq and icSHAPE for Rpl6 (a gene encoding ribosomal protein) transcript with a high correlation (Pearson correlation coefficient R: 0.789). (**c**) Left: scatter plot of AUC between Keth-seq and icSHAPE for RNAs with known structure model (18S ribosomal RNA from RNA STRAND database and others from Rfam database, 32 RNAs in total). Right: A fragment (240--285) of 18S ribosomal RNA with both Keth-seq and icSHAPE reactivity filled in the structure model. (**d**) Gini index of known rG4 regions (based on previously identified by Kwok et.al., 2016, *Nature method*) between +PDS treatment and native sample for *in vitro* (left) and *in vivo* (right). Only regions with structural information in both + PDS treatment and native conditions are retained for plotting (extended to 50-nucleotide long). (**e**) An example of Keth-seq profile around previously identified *in vitro* rG4 regions.](nihms-1547030-f0002){#F2}
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